A new base of Huapont was officially completed and put into use
On September 19, 2022, the completion and commissioning ceremony of a new base was held, the new base is located in Changshou District, Chongqing. The construction of Changshou Base started on October 8, 2019, after 2 years and 11 months of construction, the total construction area 89036.79㎡ was completed, including four buildings for API, four buildings for storage warehouses, one building fro QC, one power center and one sewage treatment station. All plants are operated by gravity flow and equipped with automatic control systems such as DCS, SIS, BMS and WMS.VIEW MORE
Huapont Pharma was awarded the 2021 Outstanding Company for National Adverse Drug Reaction Monitoring and Evaluation
The National Adverse Drug Reaction Monitoring Center commended Huapont Pharm. Due to its outstanding for performing the main responsibility. Meanwhile, Huapont Pharm. is also the only pharmaceutical manufacturer in Chongqing that has been commended. Under the leadership of the Drug Safety CommitteeVIEW MORE
Huapont passed the NMPA GMP inspection for large-scale injection
From February 22 to February 25, 2022, and from March 1 to March 4, 2022, NMPA (National Medical Products Administration), Chongqing conducted on-site inspection for large-volume injection. The officers conducted a comprehensive inspection. including the R&D area and production site of the injection solution, specifically, the quality management and control at the site,VIEW MORE
Huapont Pharm. won the title of "Green Factory"
Huapont Pharm. was successfully approved as a municipal green factory recently by Chongqing Municipal Economic and Information Commission It is the recognition of the company's green development, healthy development and sustainable development. Huapont Pharm. Will always focus on the concept of green development, adhere to green manufacturing, vigorously promote our company's development towards low consumption, green and ecological, and strive to complete the creation of national green factories.VIEW MORE
Huapont was certified with <Certificate of Intellectual Property Management System>.
Our management system of intellectual property was inspected by Zhongbiaotong International Certification (Shenzhen) Co., Ltd. from December 8th to 10th. Huapont Management system of intellectual property was accredited as complying with the "GB/T 29490-2013 Enterprise Intellectual Property Management Specification". Huapont was certified withVIEW MORE
Huapont passed the NMPA GMP inspection for sterile preparation workshop
Chongqing Municipal Drug Administration conducted an inspection for sterile preparation workshop of Huapont on December 1st ~ 2nd in 2021. During inspection, quality related management documentations were comprehensively and deeply reviewed,VIEW MORE
Moxifloxacin was approved in Japan
On February 10, 2020, Chongqing Huapont Pharmaceutical Co., Ltd. obtained the "Notice of Pharmaceutical Compliance Investigation Results" issued by the Japanese competent authority PMDA (Pharmaceuticals and Medical Devices Agency).VIEW MORE
Huapont-Shimadzu Cooperative Laboratory Established
As good cooperation between our company and Shimadzu Enterprise Management (China) Co., Ltd. for a long time , it is decided to jointly build a cooperative laboratory based on the needs of their future development strategies and to continually strengthen the cooperative relationship between the two parties.VIEW MORE